Disability Benefits for Macular Degeneration

How SSA Evaluates Macular Degeneration

Macular degeneration damages the macula, the central part of the retina responsible for sharp, straight-ahead vision. It blurs and eventually destroys the central field used for reading, recognizing faces, and detailed work, while peripheral vision is usually preserved. The Social Security Administration does not evaluate the diagnosis itself; it evaluates the resulting loss of central vision under Blue Book listing 2.02, loss of central visual acuity, measured in your better eye with best correction.

Listing 2.02 is met when:

• Your best-corrected central visual acuity in the better eye is 20/200 or worse.

This is a precise, objective standard. SSA measures the better eye because the concern is your overall remaining functional vision, and it uses best-corrected acuity — your vision with the most effective glasses or contacts. Because macular degeneration attacks central vision specifically, listing 2.02 is the usual route, though severe cases combining acuity and field loss may also be evaluated under listing 2.04 (loss of visual efficiency or visual impairment value). Both the common age-related form (wet and dry) and earlier-onset forms are evaluated the same way, by measured vision. The impairment must last, or be expected to last, at least 12 months, which macular degeneration, as a chronic and often progressive disease, readily satisfies.

Medical Evidence SSA Needs for Macular Degeneration

The central piece of evidence is best-corrected visual acuity testing in each eye, performed by an eye doctor using an acceptable chart, since the 20/200 threshold in the better eye decides listing 2.02. Because vision can fluctuate and progress, measurements over time strengthen the record.

SSA also needs an eye examination confirming the diagnosis and its cause: a dilated retinal examination describing the macular changes, and imaging such as optical coherence tomography (OCT) and, for the wet form, fluorescein angiography documenting the degeneration and any bleeding or fluid.

Document the treatment history — anti-VEGF injections for wet macular degeneration, and monitoring for the dry form — and your response, along with visual field testing if peripheral vision is also affected. An eye doctor's statement describing your functional vision, including difficulty reading and recognizing detail, adds valuable context.

Qualifying Through Your Residual Functional Capacity

Many people with macular degeneration have central acuity that is seriously impaired but not quite 20/200, and the residual functional capacity stage addresses how that loss affects work. Loss of central vision undercuts nearly all detailed tasks: reading print and screens, inspecting or assembling small items, writing, and any work requiring fine visual discrimination become difficult or impossible. Because so many jobs — clerical, technical, and skilled work — depend on reading and close visual attention, this loss can eliminate a person's past work and much of the sedentary job base.

People with macular degeneration also struggle with contrast, glare, and adapting between light and dark, and central scotomas (blind spots) interfere with tasks even when peripheral vision allows movement. These limits combine with any other impairments to reduce the work available.

For claimants 50 and older, significant visual limitation combined with the medical-vocational framework can support approval, particularly where skilled work required reading that is no longer possible. Younger claimants generally prevail by showing that the loss of detailed vision rules out the work they could otherwise do.

Tips for a Stronger Macular Degeneration Claim

Precise, current vision testing is the key.

• Make sure best-corrected acuity is measured in each eye and clearly recorded; the better-eye number decides listing 2.02.
• Keep repeat measurements over time, since progression and treatment response matter.
• Provide OCT and other retinal imaging confirming the diagnosis.
• Report concrete difficulties — cannot read regular print, cannot recognize faces, cannot do detailed tasks — so the functional loss is documented.
• Ask your eye doctor to describe how your central vision loss affects reading and close work.